Use of the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in the Diagnosis of Pleural Effusion
Evaluation of the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) as a Diagnostic Tool for Patients With Pleural Effusion
1 other identifier
observational
100
1 country
1
Brief Summary
The aim of this trial is to evaluate the level of TREM-1 in different kinds of pleural effusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 12, 2005
CompletedFirst Posted
Study publicly available on registry
September 14, 2005
CompletedNovember 24, 2005
May 1, 2005
September 12, 2005
November 23, 2005
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of pleural effusion
- Pleural effusion proved by chest sonography
You may not qualify if:
- Conditions for which thoracentesis are contraindicated
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pan-Chyr Yang, MD, PhD
Department of International Medicine, National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- NATURAL HISTORY
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 12, 2005
First Posted
September 14, 2005
Study Start
May 1, 2005
Last Updated
November 24, 2005
Record last verified: 2005-05